探索洛拉提尼布和人类α-1-酸糖蛋白之间的结合特性:多谱和分子建模技术
Huan-Yu Sui1, Dong Chen1, Jia-Ping Huang1
1College of Pharmaceutic Science, Zhejiang University of Technology, Hangzhou 310032, China.
概括
洛拉提尼布 (LOR) 通过静态火与人血清白蛋白 (HAG) 结合,插入其疏水性腔. 这种由键和范德瓦尔斯力驱动的相互作用改变了HAG.
科学领域:
- 药理学和分子生物物理学
- 药物与蛋白质相互作用 药物与蛋白质相互作用
- 生物化学 生物化学
背景情况:
- 洛拉提尼布 (LOR) 是2019年批准用于ROS1和ALK阳性癌症的向疗法.
- 了解药物蛋白相互作用对于预测药物疗效和新陈代谢至关重要.
- 人类血清白蛋白 (HAG) 是血中一种主要的药物结合蛋白.
研究的目的:
- 阐明洛拉提尼布 (LOR) 和人类血清白蛋白 (HAG) 之间的结合机制.
- 调查LOR-HAG复合体形成的结构和能量贡献.
- 探索环境因素,包括金属离子,对LOR-HAG结合的影响.
主要方法:
- 多谱光谱学 (包括同步光和3D光).
- 热力学和竞争性结合测定.
- 循环二重化 (CD) 光谱学.循环二重化 (CD) 光谱学.
- 分子建模和模拟技术.
主要成果:
- 洛拉丁尼布 (LOR) 呈现出HAG光的静态火,这表明它被插入到具有中等亲和力的疏水性腔中.
- 结合主要是由结合,疏水性相互作用和范德瓦尔斯力介导的.
- LOR结合导致HAG的二次结构和氨酸和氨酸残留物的微环境发生变化.
结论:
- 洛拉提尼布 (LOR) 通过一系列力量与人血清白蛋白 (HAG) 结合,导致蛋白质的结构变化.
- 这项研究为了解洛拉提尼布的体内行为和药理活性提供了理论基础.
- 对LOR代谢及其与生物系统相互作用的进一步研究是有必要的.
相关概念视频
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


